|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
4530738 |
003 |
ICU |
005 |
20040426214100.0 |
008 |
010614s2000 nyua b 101 0 eng c |
010 |
|
|
|a 00033647
|
020 |
|
|
|a 185070709X (alk. paper)
|
035 |
|
|
|a CTYAFNW8784-B
|
035 |
|
|
|a (CtY)notisFNW8784
|
035 |
|
|
|a 90068197
|
040 |
|
|
|a NLM
|c NLM
|d EYM
|d CtY-M
|d OrLoB-B
|d OCoLC
|
060 |
1 |
0 |
|a WP 580
|b W927m 2000
|
082 |
0 |
|
|a 618.1/75
|2 21
|
111 |
2 |
|
|a World Congress on the Menopause
|n (9th :
|d 1999 :
|c Yokohama-shi, Japan)
|
245 |
1 |
4 |
|a The menopause at the millennium :
|b the proceedings of the 9th International Menopause Society, World Congress on the Menopause /
|c edited by Takeshi Aso, Takumi Yanaihara, and Seiichiro Fujimoto.
|
260 |
|
|
|a New York :
|b Parthenon,
|c 2000.
|
300 |
|
|
|a xvii, 558 p. :
|b ill. ;
|c 27 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g 1.
|t The hypothalamo-pituitary-ovarian axis during the perimenopause /
|r H. G. Burger, E. Dudley and P. Mamers /
|r [et al.] --
|g 2.
|t Menopause: implications for women's health care in aging societies /
|r N. F. Woods --
|g 3.
|t Mechanisms of action of estrogens and antiestrogens /
|r F. Labrie, C. Labrie and A. Belanger /
|r [et al.] --
|g 4.
|t Bone loss and bone gain: how to handle them /
|r R. Ziegler --
|g 5.
|t Culture and the menopause /
|r M. Lock --
|g 6.
|t Brain function, menopause and aging /
|r A. R. Genazzani, M. Stomati and P. Monteleone --
|g 7.
|t Menopause and sexual functioning /
|r L. Dennerstein, P. Lebert and H. G. Burger /
|r [et al.] --
|g 8.
|t Cancer diseases in the menopause: causes and prevention /
|r I. R. Persson --
|g 9.
|t Aging for men /
|r B. Lunenfeld --
|g 10.
|t Healthy aging: a gender perspective /
|r M. F. Ramashala --
|g 11.
|t The significance of the menopause in human life in the present and next centuries /
|r T. Aso --
|g 12.
|t Healthy aging in the 21st century /
|r Khunying K. Limpaphayom --
|g 13.
|t Menopause in the aging society /
|r M. Birkhauser --
|g 14.
|t The climacteric in Latin America: actual state and future trends /
|r N. O. Siseles, A. P. Gutierrez and F. C. Sayegh --
|g 15.
|t Menopause and six chronic conditions of aging: the Study of Women's Health Across the Nation (SWAN) /
|r S. S. Sherman, R. E. Goldstein and S. L. Crawford /
|r [et al.] --
|g 16.
|t Role of reproductive health in the quality of life of women in the menopause /
|r B. Xiao and Q. S. Ge --
|g 17.
|t Quality of life for changing health: perimenopause among Japanese in Japan and the USA /
|r A. Noji --
|g 18.
|t The use of hormones and psychopharmacy: women's views /
|r G. V. Miranda, S. Miranda and A. F. Camargos --
|g 19.
|t Determinants and quantification of quality of life after the menopause: the Utian Menopause Quality of Life score /
|r W. H. Utian, J. W. Janata and S. A. Kingsberg /
|r [et al.] --
|g 20.
|t The menopause and ovarian cell death /
|r A. Amsterdam, K. Hosokawa and R. Gold /
|r [et al.] --
|g 21.
|t Estrogen replacement therapy: an endocrinologist's perspective /
|r H. G. Burger --
|g 22.
|t Morphological changes in reproductive organs during the aging process in perimenopausal women /
|r P. M. Motta and S. Makabe --
|g 23.
|t Xerostomia and other oral problems in the menopause /
|r T. Fujibayashi --
|g 24.
|t Connective tissue changes in the menopause and with hormone replacement therapy /
|r M. Brincat, R. Galea and Y. Muscat Baron --
|g 25.
|t Estrogen regulates lymphopoiesis /
|r P. W. Kincade, K. L. Medina and K. J. Payne /
|r [et al.] --
|g 26.
|t Eye and ear as target organs for sex hormones /
|r M. O. Sator and J. C. Huber --
|g 27.
|t The management of menopausal symptoms after breast cancer /
|r J. A. Eden --
|g 28.
|t Effects of progestogen on the breast /
|r B. von Schoultz --
|g 29.
|t Primary care during the menopause in Latin America /
|r N. R. Melo, R. M. Neme and A. H. Galvao Giribela /
|r [et al.] --
|g 30.
|t Menopause in the Asia-Pacific region /
|r C. J. Haines --
|g 31.
|t Improvement of knowledge and perception of the menopause in the Bulgarian population /
|r D. B. Georgiev and E. P. Ratchev --
|g 32.
|t Women's health care in Sweden: primary care in the menopause, actual versus ideal /
|r B.-M. Landgren --
|g 33.
|t Diet and exercise do they influence health outcomes during the menopausal transition? /
|r J. R. Guthrie --
|g 34.
|t Exercise and bone in the postmenopausal years: a reality check /
|r B. L. Drinkwater --
|g 35.
|t Physical activity, obesity and menopause /
|r K. Kawakubo and J. S. Lee --
|g 36.
|t Obesity, stress and menopause /
|r T. Moskovic and N. Antic --
|g 37.
|t Culture and medical consultation /
|r C. A. Gurucharri --
|g 38.
|t Attitudes to and practice of hormone replacement therapy in Central and Eastern Europe /
|r L. Kovacs --
|g 39.
|t Culture and aging of the female: a case of Japanese society /
|r E. Namihira --
|g 40.
|t The current status of Chinese traditional medicine treatment of postmenopausal women in Taiwan /
|r K.-E. Huang --
|g 41.
|t Dietary strategy for postmenopausal women /
|r H. M. Park --
|g 42.
|t Optimal treatment of menopausal disorder based on differential diagnosis of mental disorders /
|r T. Ushiroyama --
|g 43.
|t A patient-centered approach to managing the menopause /
|r J. Rymer --
|g 44.
|t When hormone replacement therapy is not possible /
|r M. Neves-e-Castro --
|g 45.
|t Biological actions of progesterone and progestins on breast epithelial cell cycle progression /
|r E. A. Musgrove and R. L. Sutherland --
|g 46.
|t Endometrial effects of progesterone versus progestins /
|r B. de Lignieres --
|g 47.
|t The vascular effects of progesterone/progestogens /
|r S. H. Cho --
|g 48.
|t Progestogens, progesterone: their clinical application and problems /
|r B. G. Wren --
|g 49.
|t Potential roles of estrogen receptor-[alpha] and -[beta] in the regulation of human osteoblast functions and gene expression /
|r K. M. Waters, D. J. Rickard and J. B. Gebhart /
|r [et al.] --
|g 50.
|t Treatment of osteoporosis with antiresorptive drugs: facts and controversies /
|r E. F. Eriksen and T. H. Sorensen --
|g 51.
|t Bisphosphonates in prevention and treatment of osteoporosis: state of the art /
|r J.-Y. Reginster, A. Biermans and J.-F. Monville --
|g 52.
|t Effects of menopause and estrogen replacement therapy on cerebral blood flow in women /
|r T. Ohkura --
|g 53.
|t Phytoestrogens and cardiovascular risk /
|r A. Pines --
|g 54.
|t The role of bone turnover measurement in the management of osteoporosis /
|r C. Christiansen --
|g 55.
|t Assessment of cortical and trabecular bone mass by pQCT /
|r T. Sone and M. Fukunaga --
|g 56.
|t The combination of low bone mineral density and other risk factors in osteoporosis /
|r J. A. Kanis, O. Johnell and A. Oden /
|r [et al.] --
|g 57.
|t Options for the prevention and treatment of osteoporosis /
|r M. McClung --
|g 58.
|t Food Components and menopausal health /
|r M. L. Wahlqvist and F. S. Dalais --
|g 59.
|t Soy foods, soy phytoestrogens and bone health /
|r M. J. Messina and F. S. Dalais --
|g 60.
|t Efficacy and tolerance of different kids of ERT /
|r J. Donat --
|g 61.
|t Effects of oral and transdermal HRT in relation to serum estrogen levels /
|r T. Aono, T. Yasui and H. Uemura /
|r [et al.] --
|g 62.
|t Aerodiol: estrogen replacement therapy via the nasal route for the treatment of menopausal symptoms /
|r J. Studd --
|g 63.
|t Hormones and hemostasis /
|r A. Cano --
|g 64.
|t Prescription attitudes of gynecologists towards risk and benefit situations /
|r S. Rozenberg, C. Fellemans and J. Barudy Vasquez /
|r [et al.] --
|g 65.
|t Further basic and clinical investigations into Alzheimer's disease /
|r H. Honjo, K. Tanaka and N. Kikuchi /
|r [et al.] --
|g 66.
|t Estrogen therapy and the risk of Alzheimer's disease: an update at the millennium /
|r V. W. Henderson --
|g 67.
|t Estrogen use and Alzheimer's disease: pharmacogenetic interaction by APOE genotype? /
|r A. J. C. Slooter and C. M. van Duijn --
|g 68.
|t Lipid Changes during the peri- and postmenopause and subclinical cardiovascular disease /
|r K. A. Matthews, L. H. Kuller and K. Sutton-Tyrrell /
|r [et al.] --
|g 69.
|t Effects of continuous combined HRT on lipid profile /
|r J. Y. Lee, Y. M. Choi and S. Y. Ku --
|g 70.
|t Managing postmenopausal women with hypercholesterolemia: HRT, statins or both? /
|r S. R. Davis --
|g 71.
|t Female sexual interest, response and attractiveness in relation to age, the menopause and hormone replacement therapy /
|r N. L. McCoy --
|g 72.
|t Psychosomatic aspects of sexuality among married middle-aged women /
|r F. Horiguchi, H. Ohta and S. Nozawa --
|g 73.
|t Dyspareunia: differential diagnosis and treatment guidelines /
|r A. Graziottin and E. Castoldi --
|g 74.
|t The role of selective estrogen receptor modulators in the prevention of cardiovascular disease /
|r N. K. Wenger --
|g 75.
|t The potential effects of SERMs on breast cancer prevention /
|r C. A. Stuenkel --
|g 76.
|t Raloxifene: safety considerations and side-effects /
|r D. W. Purdie --
|g 77.
|t Aging of the hypothalamic-pituitary-gonadal axis in men /
|r J. M. Kaufman --
|g 78.
|t Fertility and fertility-related problems in the aging male /
|r E. Nieschlag, M. Brinkworth and C. Rolf /
|r [et al.] --
|g 79.
|t Epidemiological correlates of erectile dysfunction (impotence) and its biomedical significance /
|r J. B. McKinlay --
|g 80.
|t Impact of urogenital aging on the quality of life /
|r D. Hudita --
|
505 |
8 |
0 |
|g 81.
|t Vaginal microecology and local immune system in postmenopausal women /
|r V. Smetnik, V. Balan and A. Ankirskaja /
|r [et al.] --
|g 82.
|t Update in assessment of the patient with postmenopausal urethrovesical dysfunction /
|r H. E. O'Connell --
|g 83.
|t Behavioral intervention for incontinence in clinical practice /
|r C. M. Sampselle --
|g 84.
|t Psychological aspects of the transition on menopause /
|r A. Collins --
|g 85.
|t Refounding the knowledge of the psychology of the menopause: longevity without aging /
|r L. Zichella --
|g 86.
|t The psychosocial vulnerability model of the menopause /
|r J. G. Greene --
|g 87.
|t Psychological perspectives of menopause: themes and images emerging in sandplay therapy /
|r S. T. Reece.
|
650 |
|
0 |
|a Menopause
|x Hormon therapy.
|
650 |
|
0 |
|a Estrogen
|x Therapeutic use.
|0 http://id.loc.gov/authorities/subjects/sh85045015
|
650 |
|
2 |
|a Menopause
|v Congresses.
|
650 |
|
7 |
|a Estrogen
|x Therapeutic use.
|2 fast
|0 http://id.worldcat.org/fast/fst00915648
|
650 |
|
7 |
|a Menopause
|x Hormone therapy.
|2 fast
|0 http://id.worldcat.org/fast/fst01016254
|
700 |
1 |
|
|a Asō, Takeshi.
|0 http://id.loc.gov/authorities/names/n00121266
|1 http://viaf.org/viaf/267893732
|
700 |
1 |
|
|a Yanaihara, Takumi.
|0 http://id.loc.gov/authorities/names/n00121764
|1 http://viaf.org/viaf/30777802
|
700 |
1 |
|
|a Fujimoto, Seiichiro.
|0 http://id.loc.gov/authorities/names/n94800037
|1 http://viaf.org/viaf/282169903
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
035 |
|
|
|a (OCoLC)224019450
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i f1d12c5c-0531-508c-9bc2-985193c93b1e
|s 90960eaf-d936-5001-a85d-dd109e1db5de
|
928 |
|
|
|t Library of Congress classification
|a RG186 .W67 1999
|l JCL
|c JCL-Sci
|i 4526109
|
927 |
|
|
|t Library of Congress classification
|a RG186 .W67 1999
|l JCL
|c JCL-Sci
|e CRERAR
|b 59622523
|i 7135078
|